Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Spontaneous molecular response of IDH2 acute myeloid leukemia.

Khalife-Hachem S, Pegliasco J, Saada V, Hernandez E, Camara-Clayette V, Cotteret S, Benabdelali R, de Botton S, Marzac C, Micol JB.

Ann Hematol. 2019 Dec 9. doi: 10.1007/s00277-019-03876-8. [Epub ahead of print] No abstract available.

PMID:
31814054
2.

Impact of interferon on a triple positive polycythemia vera.

Campario H, Mosca M, Aral B, Bourgeois V, Martin P, Brustel A, Filser M, Marzac C, Plo I, Girodon F.

Leukemia. 2019 Nov 14. doi: 10.1038/s41375-019-0636-0. [Epub ahead of print] No abstract available.

PMID:
31728058
3.

Germline RUNX1 Intragenic Deletion: Implications for Accurate Diagnosis of FPD/AML.

Duployez N, Martin JE, Khalife-Hachem S, Benkhelil R, Saada V, Marzac C, Auger N, Marceau-Renaut A, Favier R, Ballerini P, Caron O, Baruchel A, de Botton S, Preudhomme C, Micol JB, Raslova H, Antony-Debré I.

Hemasphere. 2019 Jun 4;3(3):e203. doi: 10.1097/HS9.0000000000000203. eCollection 2019 Jun. No abstract available.

4.

Next-generation sequencing discriminates myelodysplastic/myeloproliferative neoplasms from paraneoplastic leukemoid reaction in cancer patients with hyperleukocytosis.

Sakr R, Renneville A, Saada V, Cotteret S, Martin JE, Droin N, Selimoglu-Buet D, Besse B, Hollebecque A, Marzac C, Pasquier F, Micol JB, De Botton S, Mir O, Solary E, Willekens C.

Leuk Lymphoma. 2018 Jul;59(7):1742-1745. doi: 10.1080/10428194.2017.1397669. Epub 2017 Nov 8. No abstract available.

PMID:
29115897
5.

T-cell prolymphocytic leukemia and tuberculosis: a puzzling association.

Cervera P, Gilhot A, Marzac C, Féger F, Tang R, Jaff N, Coppo P.

Clin Case Rep. 2017 Aug 10;5(9):1536-1541. doi: 10.1002/ccr3.1121. eCollection 2017 Sep.

6.

Reply to: "Calreticulin mutations and their importance in Budd-Chiari syndrome".

Poisson J, Turon F, Marzac C, Valla DC, Garcia-Pagan JC, Rautou PE.

J Hepatol. 2017 Nov;67(5):1112-1113. doi: 10.1016/j.jhep.2017.06.018. Epub 2017 Jun 27. No abstract available.

PMID:
28662846
7.

Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study.

Poisson J, Plessier A, Kiladjian JJ, Turon F, Cassinat B, Andreoli A, De Raucourt E, Goria O, Zekrini K, Bureau C, Lorre F, Cervantes F, Colomer D, Durand F, Garcia-Pagan JC, Casadevall N, Valla DC, Rautou PE, Marzac C; French national network for vascular liver diseases.

J Hepatol. 2017 Sep;67(3):501-507. doi: 10.1016/j.jhep.2017.04.021. Epub 2017 May 5.

PMID:
28483676
8.

Precision and prognostic value of clone-specific minimal residual disease in acute myeloid leukemia.

Hirsch P, Tang R, Abermil N, Flandrin P, Moatti H, Favale F, Suner L, Lorre F, Marzac C, Fava F, Mamez AC, Lapusan S, Isnard F, Mohty M, Legrand O, Douay L, Bilhou-Nabera C, Delhommeau F.

Haematologica. 2017 Jul;102(7):1227-1237. doi: 10.3324/haematol.2016.159681. Epub 2017 Mar 16.

9.

Mature CD8+ T-cell clonal expansion in the oral cavity and digestive tract: a severe lymphoid malignancy that mimics Crohn's disease.

Coppo P, Fabiani B, Marzac C, Sokol H.

Clin Case Rep. 2016 Oct 11;4(12):1088-1090. eCollection 2016 Dec.

10.

Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.

Hirsch P, Zhang Y, Tang R, Joulin V, Boutroux H, Pronier E, Moatti H, Flandrin P, Marzac C, Bories D, Fava F, Mokrani H, Betems A, Lorre F, Favier R, Féger F, Mohty M, Douay L, Legrand O, Bilhou-Nabera C, Louache F, Delhommeau F.

Nat Commun. 2016 Aug 18;7:12475. doi: 10.1038/ncomms12475.

11.

Clonal history of a cord blood donor cell leukemia with prenatal somatic JAK2 V617F mutation.

Hirsch P, Mamez AC, Belhocine R, Lapusan S, Tang R, Suner L, Bories D, Marzac C, Fava F, Legrand O, Mohty M, Douay L, Delhommeau F.

Leukemia. 2016 Aug;30(8):1756-9. doi: 10.1038/leu.2016.31. Epub 2016 Mar 1. No abstract available.

PMID:
26876594
12.

Diversity and combinations of infectious agents in 38 adults with an infection-triggered reactive haemophagocytic syndrome: a multicenter study.

Lerolle N, Laanani M, Rivière S, Galicier L, Coppo P, Meynard JL, Molina JM, Azoulay E, Aumont C, Marzac C, Fardet L, Lambotte O.

Clin Microbiol Infect. 2016 Mar;22(3):268.e1-8. doi: 10.1016/j.cmi.2015.11.018. Epub 2015 Dec 12.

13.

Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients.

Cabagnols X, Favale F, Pasquier F, Messaoudi K, Defour JP, Ianotto JC, Marzac C, Le Couédic JP, Droin N, Chachoua I, Favier R, Diop MK, Ugo V, Casadevall N, Debili N, Raslova H, Bellanné-Chantelot C, Constantinescu SN, Bluteau O, Plo I, Vainchenker W.

Blood. 2016 Jan 21;127(3):333-42. doi: 10.1182/blood-2015-07-661983. Epub 2015 Oct 8.

PMID:
26450985
14.

Hepatic nodular lymphoid lesion with increased IgG4-positive plasma cells associated with primary biliary cirrhosis: a report of two cases.

Calvo J, Carbonell N, Scatton O, Marzac C, Ganne-Carrie N, Wendum D.

Virchows Arch. 2015 Nov;467(5):613-7. doi: 10.1007/s00428-015-1841-5. Epub 2015 Sep 10.

PMID:
26358058
15.

Epstein-Barr virus viral load in human immunodeficiency virus-positive patients with reactive hemophagocytic syndrome.

Boisseau M, Lambotte O, Galicier L, Lerolle N, Marzac C, Aumont C, Coppo P, Fardet L.

Infect Dis (Lond). 2015 Jun;47(6):423-7. doi: 10.3109/00365548.2015.1007475. Epub 2015 Mar 6.

PMID:
25746607
16.

Endogenous megakaryocytic colonies underline association between megakaryocytes and calreticulin mutations in essential thrombocythemia.

Mondet J, Park JH, Menard A, Marzac C, Carillo S, Pourcelot E, Girodon F, Cabagnols X, Lodé L, Socoro N, Chauvet M, Bulabois CE, Cony-Makhoul P, Corm S, Cahn JY, Mossuz P.

Haematologica. 2015 May;100(5):e176-8. doi: 10.3324/haematol.2014.118927. Epub 2015 Feb 6. No abstract available.

17.

Prognosis of body mass index and chemotherapy dose capping in acute myeloid leukaemia.

Kempf E, Hirsch P, Labopin M, Viguié F, Isnard F, Tang R, Marzac C, Marie JP, Mohty M, Legrand O.

Leuk Res. 2014 Dec;38(12):1425-9. doi: 10.1016/j.leukres.2014.09.013. Epub 2014 Oct 7.

PMID:
25443887
18.

Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: relevance for disease evolution.

Cabagnols X, Defour JP, Ugo V, Ianotto JC, Mossuz P, Mondet J, Girodon F, Alexandre JH, Mansier O, Viallard JF, Lippert E, Murati A, Mozziconacci MJ, Saussoy P, Vekemans MC, Knoops L, Pasquier F, Ribrag V, Solary E, Plo I, Constantinescu SN, Casadevall N, Vainchenker W, Marzac C, Bluteau O.

Leukemia. 2015 Jan;29(1):249-52. doi: 10.1038/leu.2014.270. Epub 2014 Sep 12. No abstract available.

PMID:
25212275
19.

Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide.

Arca M, Fardet L, Galicier L, Rivière S, Marzac C, Aumont C, Lambotte O, Coppo P.

Br J Haematol. 2015 Jan;168(1):63-8. doi: 10.1111/bjh.13102. Epub 2014 Aug 26.

PMID:
25157895
20.

Interest of cytogenetic and FISH evaluation for prognosis evaluation in 198 patients with acute myeloid leukemia in first complete remission in a single institution.

Hirsch P, Labopin M, Viguié F, Perot C, Isnard F, Mamez AC, Bilhou-Nabera C, Marzac C, Delhommeau F, Lapusan S, Marie JP, Mohty M, Legrand O.

Leuk Res. 2014 Aug;38(8):907-12. doi: 10.1016/j.leukres.2014.05.021. Epub 2014 Jun 4.

PMID:
24957411
21.

Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients.

Rivière S, Galicier L, Coppo P, Marzac C, Aumont C, Lambotte O, Fardet L.

Am J Med. 2014 Nov;127(11):1118-25. doi: 10.1016/j.amjmed.2014.04.034. Epub 2014 May 14.

PMID:
24835040
22.

Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.

Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, Coppo P, Hejblum G.

Arthritis Rheumatol. 2014 Sep;66(9):2613-20. doi: 10.1002/art.38690.

23.

Acute myeloid leukemia in patients older than 75: prognostic impact of FLT3-ITD and NPM1 mutations.

Hirsch P, Qassa G, Marzac C, Tang R, Perrot JY, Isnard F, Mohty M, Marie JP, Legrand O.

Leuk Lymphoma. 2015 Jan;56(1):147-50. doi: 10.3109/10428194.2014.913288. Epub 2014 Jun 16.

PMID:
24724782
24.

A web-based delphi study for eliciting helpful criteria in the positive diagnosis of hemophagocytic syndrome in adult patients.

Hejblum G, Lambotte O, Galicier L, Coppo P, Marzac C, Aumont C, Fardet L.

PLoS One. 2014 Apr 7;9(4):e94024. doi: 10.1371/journal.pone.0094024. eCollection 2014.

25.

The spectrum of chronic CD8+ T-cell expansions: clinical features in 14 patients.

Ghrenassia E, Roulin L, Aline-Fardin A, Marzac C, Féger F, Gay J, Pacanowski J, Hertig A, Coppo P.

PLoS One. 2014 Mar 11;9(3):e91505. doi: 10.1371/journal.pone.0091505. eCollection 2014.

26.

Long-term imatinib maintenance therapy for adult Philadelphia positive acute lymphoblastic leukemia.

Guillet S, Hirsch P, Marzac C, Mohty M, Marie JP, Legrand O.

Leuk Lymphoma. 2014 Nov;55(11):2646-8. doi: 10.3109/10428194.2014.889828. Epub 2014 Mar 10. No abstract available.

PMID:
24491028
27.

Effect of EDTA-anticoagulated whole blood storage on cell morphology examination. A need for standardization.

Vives-Corrons JL, Briggs C, Simon-Lopez R, Albarede S, de la Salle B, Flegar-Meatrii Z, Nazor A, Guyard A, Lipsic T, Nagai Y, Patiu M, Piqueras J, Capel MJ, Van Blerk M, Wang J, Marzac C.

Int J Lab Hematol. 2014 Apr;36(2):222-6. doi: 10.1111/ijlh.12170. Epub 2013 Dec 12. No abstract available.

PMID:
24330572
28.

Beware of hidden trains: simultaneous discovery of a MYH9-related disease and chronic lymphocytic leukaemia.

Chaquin M, Marzac C, Legrand O, Favier R.

Br J Haematol. 2014 Jan;164(2):162. doi: 10.1111/bjh.12583. Epub 2013 Oct 10. No abstract available.

PMID:
24117195
29.

Prognostic impact of high ABC transporter activity in 111 adult acute myeloid leukemia patients with normal cytogenetics when compared to FLT3, NPM1, CEBPA and BAALC.

Hirsch P, Tang R, Marzac C, Perrot JY, Fava F, Bernard C, Jeziorowska D, Marie JP, Legrand O.

Haematologica. 2012 Feb;97(2):241-5. doi: 10.3324/haematol.2010.034447. Epub 2011 Nov 4.

30.

ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients.

Marzac C, Garrido E, Tang R, Fava F, Hirsch P, De Benedictis C, Corre E, Lapusan S, Lallemand JY, Marie JP, Jacquet E, Legrand O.

Haematologica. 2011 Sep;96(9):1293-301. doi: 10.3324/haematol.2010.031823. Epub 2011 May 23.

31.

Reactive haemophagocytic syndrome in 58 HIV-1-infected patients: clinical features, underlying diseases and prognosis.

Fardet L, Lambotte O, Meynard JL, Kamouh W, Galicier L, Marzac C, de Labarthe A, Cabane J, Lebbe C, Coppo P, Molina JM, Martinez V.

AIDS. 2010 Jun 1;24(9):1299-306. doi: 10.1097/QAD.0b013e328339e55b.

PMID:
20559036
32.

Molecular aspects of myeloproliferative neoplasms.

Delhommeau F, Jeziorowska D, Marzac C, Casadevall N.

Int J Hematol. 2010 Mar;91(2):165-73. doi: 10.1007/s12185-010-0530-z. Epub 2010 Feb 27. Review.

PMID:
20186505
33.

High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia.

Tang R, Hirsch P, Fava F, Lapusan S, Marzac C, Teyssandier I, Pardo J, Marie JP, Legrand O.

Blood. 2009 Oct 1;114(14):2993-3000. doi: 10.1182/blood-2009-05-223115. Epub 2009 Jul 30.

PMID:
19643984
34.

Mutation in TET2 in myeloid cancers.

Delhommeau F, Dupont S, Della Valle V, James C, Trannoy S, Massé A, Kosmider O, Le Couedic JP, Robert F, Alberdi A, Lécluse Y, Plo I, Dreyfus FJ, Marzac C, Casadevall N, Lacombe C, Romana SP, Dessen P, Soulier J, Viguié F, Fontenay M, Vainchenker W, Bernard OA.

N Engl J Med. 2009 May 28;360(22):2289-301. doi: 10.1056/NEJMoa0810069.

35.

Vasculogenic mimicry of acute leukemic bone marrow stromal cells.

Mirshahi P, Rafii A, Vincent L, Berthaut A, Varin R, Kalantar G, Marzac C, Calandini OA, Marie JP, Soria C, Soria J, Mirshahi M.

Leukemia. 2009 Jun;23(6):1039-48. doi: 10.1038/leu.2009.10. Epub 2009 Apr 2.

PMID:
19340002
36.

Correlation between molecular and histopathological diagnoses of B cell lymphomas in bone marrow biopsy and aspirates.

Ilgenfritz RB, Kayasut K, Le Tourneau A, Calendini OA, Ouafi L, Marzac C, Diebold J, Devez F, Ducruit V, Bouchet PE, Audouin J, Molina TJ.

J Clin Pathol. 2009 Apr;62(4):357-60. doi: 10.1136/jcp.2008.061622.

PMID:
19329714
37.

Concordance of assays designed for the quantification of JAK2V617F: a multicenter study.

Lippert E, Girodon F, Hammond E, Jelinek J, Reading NS, Fehse B, Hanlon K, Hermans M, Richard C, Swierczek S, Ugo V, Carillo S, Harrivel V, Marzac C, Pietra D, Sobas M, Mounier M, Migeon M, Ellard S, Kröger N, Herrmann R, Prchal JT, Skoda RC, Hermouet S.

Haematologica. 2009 Jan;94(1):38-45. doi: 10.3324/haematol.13486. Epub 2008 Nov 10.

38.

The V617F JAK 2 mutation is not a frequent event in patients with cerebral venous thrombosis without overt chronic myeloproliferative disorder.

Bellucci S, Cassinat B, Bonnin N, Marzac C, Crassard I.

Thromb Haemost. 2008 Jun;99(6):1119-20. doi: 10.1160/TH08-02-0081. No abstract available.

PMID:
18521518
39.

Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients.

Kouroupi E, Zoi K, Parquet N, Zoi C, Kiladjian JJ, Grigoraki V, Vainchenker W, Lellouche F, Marzac C, Schlageter MH, Dosquet C, Scott LM, Fenaux P, Loukopoulos D, Chomienne C, Cassinat B.

Br J Haematol. 2008 Aug;142(4):676-9. doi: 10.1111/j.1365-2141.2008.07223.x. Epub 2008 May 22. No abstract available.

PMID:
18503583
40.

[Münchausen syndrome with forgery on biologic results. A case report].

Thabuy F, Marzac C, Renaud MC, Fardet L, Tiev K, Tolédano C, Texier PL, Cabane J, Kettaneh A.

Rev Med Interne. 2008 Nov;29(11):924-8. doi: 10.1016/j.revmed.2008.02.004. Epub 2008 Apr 2. French.

PMID:
18387714
41.

[Digital bullous lesions].

Jammal M, Tiev KP, Lenglet T, Marzac C, Gain M, Permal S, Josselin-Mahr L, Cabane J, Kettaneh A.

Rev Med Interne. 2008 Oct;29(10):821-2. doi: 10.1016/j.revmed.2007.12.016. Epub 2008 Feb 15. French. No abstract available.

PMID:
18280618
42.

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.

Kiladjian JJ, Cervantes F, Leebeek FW, Marzac C, Cassinat B, Chevret S, Cazals-Hatem D, Plessier A, Garcia-Pagan JC, Darwish Murad S, Raffa S, Janssen HL, Gardin C, Cereja S, Tonetti C, Giraudier S, Condat B, Casadevall N, Fenaux P, Valla DC.

Blood. 2008 May 15;111(10):4922-9. doi: 10.1182/blood-2007-11-125328. Epub 2008 Feb 4.

PMID:
18250227
43.

Endogenous erythroid colony formation in patients with retinal vein occlusion.

Héron E, Marzac C, Feldman-Billard S, Girmens JF, Paques M, Delarue R, Piette JC, Casadevall N, Hermine O.

Ophthalmology. 2007 Dec;114(12):2155-61.

PMID:
18054634
44.

Use of hematopoietic progenitor cell count on the Sysmex XE-2100 for peripheral blood stem cell harvest monitoring.

Letestu R, Marzac C, Audat F, Belhocine R, Tondeur S, Baccini V, Garçon L, Cortivo LD, Perrot JY, Lefrère F, Valensi F, Ajchenbaum-Cymbalista F.

Leuk Lymphoma. 2007 Jan;48(1):89-96.

PMID:
17327950
45.

Flt3 internal tandem duplication and P-glycoprotein functionality in 171 patients with acute myeloid leukemia.

Marzac C, Teyssandier I, Calendini O, Perrot JY, Faussat AM, Tang R, Casadevall N, Marie JP, Legrand O.

Clin Cancer Res. 2006 Dec 1;12(23):7018-24.

46.

Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells.

Tang R, Faussat AM, Majdak P, Marzac C, Dubrulle S, Marjanovic Z, Legrand O, Marie JP.

Mol Cancer Ther. 2006 Mar;5(3):723-31.

47.

Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis.

James C, Delhommeau F, Marzac C, Teyssandier I, Couédic JP, Giraudier S, Roy L, Saulnier P, Lacroix L, Maury S, Tulliez M, Vainchenker W, Ugo V, Casadevall N.

Leukemia. 2006 Feb;20(2):350-3. No abstract available.

PMID:
16341032
48.

MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia.

Benderra Z, Faussat AM, Sayada L, Perrot JY, Tang R, Chaoui D, Morjani H, Marzac C, Marie JP, Legrand O.

Clin Cancer Res. 2005 Nov 1;11(21):7764-72.

49.

Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera.

Ugo V, Marzac C, Teyssandier I, Larbret F, Lécluse Y, Debili N, Vainchenker W, Casadevall N.

Exp Hematol. 2004 Feb;32(2):179-87.

PMID:
15102479

Supplemental Content

Loading ...
Support Center